The clinical spectrum of autoimmune congenital heart block.

Abstract

Autoimmune congenital heart block (CHB) is an immune-mediated acquired disease that is associated with the placental transference of maternal antibodies specific for Ro and La autoantigens. The disease develops in a fetal heart without anatomical abnormalities that could otherwise explain the block, and which is usually diagnosed in utero, but also at birth or within the neonatal period. Autoantibody-mediated damage of fetal conduction tissues causes inflammation and fibrosis and leads to blockage of signal conduction at the atrioventricular (AV) node. Irreversible complete AV block is the principal cardiac manifestation of CHB, although some babies might develop other severe cardiac complications, such as endocardial fibroelastosis or valvular insufficiency, even in the absence of cardiac block. In this Review, we discuss the epidemiology, classification and management of women whose pregnancies are affected by autoimmune CHB, with a particular focus on the autoantibodies associated with autoimmune CHB and how we should test for these antibodies and diagnose this disease. Without confirmed effective preventive or therapeutic strategies and further research on the aetiopathogenic mechanisms, autoimmune CHB will remain a severe life-threatening disorder.

• Authors: Pilar Brito-Zerón, Peter M Izmirly, Manuel Ramos-Casals, Jill P Buyon, Munther A Khamashta
• Journal: Nature reviews. Rheumatology (Nat Rev Rheumatol) Vol. 11 Issue 5 Pg. 301-12 (May 2015) ISSN: 1759-4804 [Electronic] United States
• PMID: 25800217 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review)

Chemical References

• Autoantibodies
• Autoantigens

Topics

• Autoantibodies (immunology)
• Autoantigens (immunology)
• Autoimmune Diseases (immunology)
• Female
• Heart Block (congenital, diagnosis, immunology)
• Humans
• Infant
• Pregnancy